Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. implant providing
Show results for
Products
Services

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Implant Providing Articles & Analysis

21 news found

CELLINK and Ossiform Enter a Strategic Partnership to launch Ossi Ink, a printable bioink based on Ossiform’s P3D Bone material

CELLINK and Ossiform Enter a Strategic Partnership to launch Ossi Ink, a printable bioink based on Ossiform’s P3D Bone material

While the advent of personalized bone implants provides a treatment pathway that can drastically improve the quality of life for many of these patients. ...

ByCELLINK


Active Implants Receives FDA Breakthrough Device Designation for NUsurface Meniscus Implant

Active Implants Receives FDA Breakthrough Device Designation for NUsurface Meniscus Implant

Active Implants, LLC, a developer of orthopedic implant solutions for joint preservation, today announced that the NUsurface® Meniscus Implant has been granted a Breakthrough Device Designation from the U.S. ...

ByActive Implants LLC


3DBio Therapeutics and the Microtia-Congenital Ear Deformity Institute Conduct Human Ear Reconstruction Using 3D-Bioprinted Living Tissue Implant in a First-in-Human Clinical Trial

3DBio Therapeutics and the Microtia-Congenital Ear Deformity Institute Conduct Human Ear Reconstruction Using 3D-Bioprinted Living Tissue Implant in a First-in-Human Clinical Trial

3DBio Therapeutics (3DBio), a clinical-stage regenerative medicine company, and the Microtia-Congenital Ear Deformity Institute announced they have conducted a human ear reconstruction using the AuriNovo™ implant, an investigational, patient-matched, 3D-bioprinted living tissue ear implant. ...

By3DBio Therapeutics


Exsomed Corporation Announces FDA 510(K) Clearance of the Nanophix Cannulated Lag Screw System for Fracture Fragments

Exsomed Corporation Announces FDA 510(K) Clearance of the Nanophix Cannulated Lag Screw System for Fracture Fragments

The cannulated lag screw provides surgeons with a sterile, surgically efficient solution to optimize outcomes of common fragment fracture surgeries such as avulsion, mallet, and condylar fractures. ...

ByExsoMed Corporation


Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL Sinus Implant Reduces Healthcare Resource Utilization

Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL Sinus Implant Reduces Healthcare Resource Utilization

Intersect ENT’s PROPEL sinus implants uniquely provide mechanical stenting of a patient’s sinuses while providing localized delivery of the corticosteroid mometasone furoate directly to healing sinus tissue, features that have been shown previously to improve outcomes after sinus surgery.1-3 “As one of the first observational ...

ByIntersect ENT, Inc.


Glaukos’ iDose TR Demonstrates Sustained IOP Reduction and Favorable Safety Profile Over 36 Months in Phase 2b Study

Glaukos’ iDose TR Demonstrates Sustained IOP Reduction and Favorable Safety Profile Over 36 Months in Phase 2b Study

--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its iDose® TR sustained-release travoprost implant continued to provide sustained substantial reductions in intraocular ...

ByGlaukos Corporation


Contraline Secures $10.7M Series A

Contraline Secures $10.7M Series A

Contraline, Inc., a venture-backed medical device company devoted to providing men and couples with long-lasting, safe, and effective male contraception, has closed $10.7 million in its Series A financing. ...

ByContraline, Inc.


Medtronic to Acquire Intersect ENT

Medtronic to Acquire Intersect ENT

Intersect ENT's PROPEL® and SINUVA® sinus implants are clinically proven solutions that open sinus passageways and deliver an anti-inflammatory steroid to aid in healing. ...

ByIntersect ENT, Inc.


U.S. Nationwide Commercial Availability of the VenSure Balloon Sinus Dilation System and Cube Navigation System Highlight Intersect ENT’s Continued Commitment to Providing Innovative, Solutions for Patients with Chronic Rhinosinusitis

U.S. Nationwide Commercial Availability of the VenSure Balloon Sinus Dilation System and Cube Navigation System Highlight Intersect ENT’s Continued Commitment to Providing Innovative, Solutions for Patients with Chronic Rhinosinusitis

“Balloon sinus dilation offers CRS patients a convenient, less-invasive, lower-cost solution by providing rapid resolution of symptoms with a minimal risk of complications. ...

ByIntersect ENT, Inc.


Active Implants’ NUsurface Meniscus Implant Provides Statistically Superior Pain Relief

Active Implants’ NUsurface Meniscus Implant Provides Statistically Superior Pain Relief

Active Implants, LLC, a developer of orthopedic implant solutions for joint preservation, today announced two-year results of the MERCURY study, which showed that the company’s NUsurface® Meniscus Implant provides statistically superior pain relief beginning at six months compared to non-surgical therapy. ...

ByActive Implants LLC


Expand Post-Market Study Evaluating Longer-Term Outcomes of PROPEL Contour Sinus Implant in the Frontal Sinus Ostia Following In-Office Balloon Sinus Dilation

Expand Post-Market Study Evaluating Longer-Term Outcomes of PROPEL Contour Sinus Implant in the Frontal Sinus Ostia Following In-Office Balloon Sinus Dilation

The PROPEL Contour Steroid Releasing Sinus Implant The PROPEL Contour sinus implant is intended to maintain patency of the frontal and maxillary sinus ostia and locally deliver steroid to the sinus mucosa in patients ≥18 years of age following sinus surgery. ...

ByIntersect ENT, Inc.


CMS Consolidates SINUVA Sinus Implant Coverage Under a Distinct Code, J7402, and Publishes an ASP Clarifying Payment and Easing Payer Coverage Adjudication

CMS Consolidates SINUVA Sinus Implant Coverage Under a Distinct Code, J7402, and Publishes an ASP Clarifying Payment and Easing Payer Coverage Adjudication

(Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that the Centers for Medicare and Medicaid Services (CMS) published an average selling price (ASP) for the Company’s SINUVA sinus implant, providing predictability, transparency, and confidence of reimbursement ...

ByIntersect ENT, Inc.


PolyActiva successfully completes initial clinical trial with Latanoprost FA SR Ocular Implant delivering glaucoma treatment to patients over a six-month period

PolyActiva successfully completes initial clinical trial with Latanoprost FA SR Ocular Implant delivering glaucoma treatment to patients over a six-month period

The study also showed that the implant persists for the entire 6-month treatment period after which the implant biodegrades completely over six weeks. This biodegradation profile should enable repeat dosing with the implant. The Latanoprost FA SR Ocular Implant is designed to substitute for daily drop therapy by ...

ByPolyActiva Pty Ltd.


PolyActiva appoints Tracy Valorie, ophthalmic industry expert and former Bausch + Lomb executive, to its Board of Directors

PolyActiva appoints Tracy Valorie, ophthalmic industry expert and former Bausch + Lomb executive, to its Board of Directors

"The company's technology has unique capabilities that have the potential to serve patients across a variety of ophthalmic disorders." "The implants provide sustained treatment that can be tailored for the indication. ...

ByPolyActiva Pty Ltd.


First U.S. Patient Treated in OASIS Clinical Trial of RENOVA iStim System for Overactive Bladder

First U.S. Patient Treated in OASIS Clinical Trial of RENOVA iStim System for Overactive Bladder

RENOVA is a tiny, battery-less and lead-less neurostimulation implant that provides a patient-centric, home-based alternative therapy option for women with OAB “Overactive bladder can be debilitating and stressful. ...

ByBlueWind Medical


BlueWind Initiates U.S. Enrollment in Clinical Trial of the RENOVA iStim to Treat Overactive Bladder

BlueWind Initiates U.S. Enrollment in Clinical Trial of the RENOVA iStim to Treat Overactive Bladder

RENOVA is a tiny, battery-less and lead-less neurostimulation implant that provides a patient-centric, home-based alternative therapy option for women with OAB. ...

ByBlueWind Medical


Planmeca and Navigate Surgical Technologies Join Forces to Launch Innovative Solutions for Dental Im

Planmeca and Navigate Surgical Technologies Join Forces to Launch Innovative Solutions for Dental Im

Dental manufacturer Planmeca and Navigate Surgical Technologies (NST), a provider of real-time surgical navigation solutions, are pleased to announce their cooperation. This partnership aims to provide dental implant surgeons with technological innovations that will deliver enhanced patient outcomes through improved accuracy and precision, as ...

ByNavigate Surgical Technologies Inc.


IlluminOss Medical Receives Clearance to Expand Clinical Indications in the U.S.

IlluminOss Medical Receives Clearance to Expand Clinical Indications in the U.S.

” Using the IlluminOss System, a patient-conforming implant is created to provide strength and stability over the entire length of the implant supporting the weakened bone. ...

ByIlluminOss Medical, Inc.


Centric Medical Announces FDA 510(K) Clearance of the Foot and Ankle Plating System

Centric Medical Announces FDA 510(K) Clearance of the Foot and Ankle Plating System

Centric Medical, a division of Life Spine, Inc., which focuses on developing surgical implants for the treatment of distal extremity pathology announced today the FDA 510(k) clearance of the new Foot and Ankle Plating System. ...

ByCentric Medical, LLC


IlluminOss Medical Granted FDA Marketing Clearance for the IlluminOss Bone Stabilization System

IlluminOss Medical Granted FDA Marketing Clearance for the IlluminOss Bone Stabilization System

The surgeon then activates a light source which delivers visible light to the PET balloon, polymerizing the monomer. The cured, hardened implant provides longitudinal strength and rotational stability over the length of the implant, stabilizing the fracture. ...

ByIlluminOss Medical, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT